The Group's principal
activities are discovering and developing of new drugs. The Group
through two segments: Discovery and development services and Discovery
Programs Division. The Group's discovery and development services
provides screening, assay development, chemical compound optimisation
production and disease targets. The discovery programs division focuses
on internal discovery programs. The Group operates in Europe, USA and
of the World.